干细胞——SMi的第二届年度会议：在科学与商业化方面取得成功
Stem Cells - SMi's second annual conference: achieving success in science and commercialisation.
作者信息
Lucifero Diana
机构信息
Thomson Reuters, 77 Hatton Garden, London, UK.
出版信息
IDrugs. 2010 Apr;13(4):232-4.
PMID:20373250
Abstract
SMi's second annual Stem Cells conference, held in London, included topics covering research developments in the field of stem cell biology and regenerative medicine. This conference report highlights selected presentations on big pharma's perspective on the field, stem cell-based therapies for chronic liver disease and age-related macular degeneration, and strategies to gain approval for the conduct of clinical trials involving stem cells. Investigational drugs discussed include GRNOPC-1 (Geron Corp).
摘要
SMi举办的第二届年度干细胞会议在伦敦召开，会议主题涵盖干细胞生物学与再生医学领域的研究进展。本会议报告重点介绍了部分演讲内容，包括大型制药公司对该领域的看法、针对慢性肝病和年龄相关性黄斑变性的干细胞疗法，以及获得涉及干细胞的临床试验开展批准的策略。所讨论的研究药物包括GRNOPC-1（杰龙公司）。
Zotero 插件